The Brain Imaging Devices Market was valued at USD 5.65 billion in 2024, and is projected to reach USD 9.03 billion by 2030, rising at a CAGR of 8.20%. Key drivers propelling market growth include technological advancements, increasing R&D activities, and the growing prevalence of brain or neurological disorders. For instance, the International Agency for Research on Cancer reported approximately 321,731 cases of brain and central nervous system cancer worldwide in 2022. This type of cancer was noted to rank 19th among all other types of cancer.
Technological advancements are expected to be one of the primary factors contributing to market growth. These advancements encompass a spectrum of innovations, including enhanced imaging resolution, improved data processing capabilities, and the development of novel imaging modalities. Such progress not only enhances the accuracy and efficiency of brain imaging but also expands its applications across various fields such as neuroscience, neurology, psychiatry, and neurosurgery. For instance, in February 2024, Philips partnered with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions, to introduce Smart Quant Neuro 3D, marking a notable advancement in providing objective decision support for the diagnosis and assessment of therapy effectiveness in brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology provides automated measurements of various brain tissues, aids in decision-making for brain diseases, monitors disease progression, and assesses therapy results.
Additionally, the rising prevalence of neurological disorders and an aging population contribute to the increasing demand for advanced brain imaging technologies. With continuous research and development efforts driving innovation and the expansion of the market. Furthermore, various initiatives undertaken by market players are further expected to contribute to market growth. For instance, in November 2022, Neurosteer secured FDA approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The company innovatively improved the conventional EEG system by incorporating an adhesive-backed electrode strip, seamlessly linking to a compact sensor, thus offering a more simplified and user-friendly solution.
This product will be delivered within 1-3 business days.
Technological advancements are expected to be one of the primary factors contributing to market growth. These advancements encompass a spectrum of innovations, including enhanced imaging resolution, improved data processing capabilities, and the development of novel imaging modalities. Such progress not only enhances the accuracy and efficiency of brain imaging but also expands its applications across various fields such as neuroscience, neurology, psychiatry, and neurosurgery. For instance, in February 2024, Philips partnered with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions, to introduce Smart Quant Neuro 3D, marking a notable advancement in providing objective decision support for the diagnosis and assessment of therapy effectiveness in brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology provides automated measurements of various brain tissues, aids in decision-making for brain diseases, monitors disease progression, and assesses therapy results.
Additionally, the rising prevalence of neurological disorders and an aging population contribute to the increasing demand for advanced brain imaging technologies. With continuous research and development efforts driving innovation and the expansion of the market. Furthermore, various initiatives undertaken by market players are further expected to contribute to market growth. For instance, in November 2022, Neurosteer secured FDA approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The company innovatively improved the conventional EEG system by incorporating an adhesive-backed electrode strip, seamlessly linking to a compact sensor, thus offering a more simplified and user-friendly solution.
Brain Imaging Devices Report Highlights
- The devices segment dominated the market with the largest revenue share of 81.5% in 2024.
- The brain tumor segment held the largest revenue share in 2024, attributed to the increasing prevalence of the condition.
- The fixed segment dominated the brain imaging devices industry with the largest revenue share in 2024.
- The hospital segment held the largest revenue share in 2024.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Brain Imaging Devices Market Variables, Trends, & Scope
Chapter 4. Brain Imaging Devices Market: Product Estimates & Trend Analysis
Chapter 5. Brain Imaging Devices Market: Application Estimates & Trend Analysis
Chapter 6. Brain Imaging Devices Market: Modality Estimates & Trend Analysis
Chapter 7. Brain Imaging Devices Market: End Use Estimates & Trend Analysis
Chapter 8. Brain Imaging Devices Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this Brain Imaging Devices market report include:- GE Healthcare
- Koninklijke Philips N.V.
- Siemens Healthineers
- Medtronic
- Compumedics Limited
- MEGIN
- CTF MEG NEURO INNOVATIONS, INC
- FieldLine Inc
- Cerca Magnetics Limited
- Advanced Brain Monitoring, Inc.
- CANON MEDICAL SYSTEMS CORPORATION
- Natus
- Magstim EGI
- Cadwell Industries Inc.
- Nihon Kohden Corporation
- NeuroLogica Corp.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 220 |
Published | May 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 5.65 Billion |
Forecasted Market Value ( USD | $ 9.03 Billion |
Compound Annual Growth Rate | 8.2% |
Regions Covered | Global |
No. of Companies Mentioned | 17 |